241 Avsnitt

  1. Pyxis Oncology's Lara Sullivan, M.D. On Site-Specific ADCs And Change Management

    Publicerades: 2022-06-13

  2. The Biotech Beatdown With Allan Shaw

    Publicerades: 2022-06-06

  3. Inflammation & Antibodies with Ampio Pharmaceuticals' Mike Martino, CEO

    Publicerades: 2022-05-30

  4. What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.

    Publicerades: 2022-05-23

  5. Running Interference: RNAi with Silence Therapeutics' Craig Tooman

    Publicerades: 2022-05-16

  6. Live Biologics & The Microbiome With 4D pharma's Duncan Peyton

    Publicerades: 2022-05-09

  7. Gene Tx For Renal Disease With Purespring CEO Richard Francis

    Publicerades: 2022-05-02

  8. Fighting Blindness & Funding The Fight With Opus Genetics' CEO Ben Yerxa, Ph.D.

    Publicerades: 2022-04-25

  9. Gynecological Cancer Therapies with Context Therapeutics' Martin Lehr

    Publicerades: 2022-04-18

  10. Commensal Viral Vectors with Ring Therapeutics' Tuyen Ong, M.D.

    Publicerades: 2022-04-11

  11. Antibodies For Severe Allergies With IgGenix's Jessica Grossman, M.D.

    Publicerades: 2022-04-04

  12. Gene Therapies For Ocular Disease With Sparing Vision's Stéphane Boissel

    Publicerades: 2022-03-28

  13. Biotech M&A Trends With Allan Shaw

    Publicerades: 2022-03-21

  14. Lipid Nanoparticle Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.

    Publicerades: 2022-03-14

  15. CAR T-cells For Ovarian Cancer with Anixa Biosciences' Amit Kumar, Ph.D.

    Publicerades: 2022-03-07

  16. AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D

    Publicerades: 2022-02-28

  17. Regulatory Harmonization With Aurion Biotech's Dr. Daniela Drago

    Publicerades: 2022-02-21

  18. Plant-Based Biologics With iBio's Randy Maddux

    Publicerades: 2022-02-14

  19. NK Cell Therapy Accessibility With Shoreline Biosciences' Dr. Kleanthis Xanthopoulos

    Publicerades: 2022-02-07

  20. A Hybrid mAb Manufacturing Model With John Glasspool

    Publicerades: 2022-01-31

8 / 13

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Bioprocess Online and Life Science Connect and brought to you by Cytiva.

Visit the podcast's native language site